ID

24596

Descrizione

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Keywords

versioni (2)
  1. 27/07/17 27/07/17 -
  2. 08/08/17 08/08/17 -
Caricato su

8 agosto 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Inglese

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 moduli  
Administrative Data
Descrizione

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Descrizione

subject identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
ELIGIBILITY QUESTION
Descrizione

ELIGIBILITY QUESTION

Alias
UMLS CUI-1
C0013893
Did the subject meet all the randomisation criteria?
Descrizione

randomisation criteria

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0243161
INCLUSION CRITERIA
Descrizione

INCLUSION CRITERIA

Alias
UMLS CUI-1
C1512693
Achieves a BDI focal score of ≤ 7 units at Visit 2
Descrizione

baseline dysnpnoea index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1511069
Achieves a composite VAS score of ≥120 (out of 400 maximum) on 4 or more days over the 7 days immediately prior to Visit 2.
Descrizione

VAS referring to COPD symptoms

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3536884
UMLS CUI [1,2]
C1737716
Is able to complete a Daily Record Card.
Descrizione

ability of daily documentation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0920316
UMLS CUI [1,2]
C0332173
UMLS CUI [1,3]
C0085732
Is able to demonstrate correct use of DISKUS/ACCUHALER.
Descrizione

ability to show the correct inhaler technique

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0419833
EXCLUSION CRITERIA
Descrizione

EXCLUSION CRITERIA

Alias
UMLS CUI-1
C0680251
Has less than 4 consecutive days with complete run-in DRC data within the 7 consecutive days prior to Visit 2.
Descrizione

incomplete documentation of the daily record card

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3845717
Has (in the opinion of the investigator) a clinically significant abnormal clinical haematology and chemistry or cortisol value at Visit 1.
Descrizione

abnormal clinical haematology and chemistry or cortisol level

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1332129
UMLS CUI [2]
C0428396
Has experienced a moderate or severe exacerbation of their COPD during the Run-In period.
Descrizione

COPD exacerbation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0740304
Subjects who have had a change to their COPD medication or taken non-permitted medications, other than "as required" use of VENTOLIN for the management of COPD exacerbations between Visits 1 and 2.
Descrizione

change in COPD medication or medication other than the permitted

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0024117
UMLS CUI [1,2]
C0580105
UMLS CUI [2]
C1115771
Ritorna all'inizio della pagina

Similar models

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
subject identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
ELIGIBILITY QUESTION
C0013893 (UMLS CUI-1)
Item
Did the subject meet all the randomisation criteria?
text
C0034656 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
randomisation criteria
Code List
Did the subject meet all the randomisation criteria?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
INCLUSION CRITERIA
C1512693 (UMLS CUI-1)
baseline dysnpnoea index
Item
Achieves a BDI focal score of ≤ 7 units at Visit 2
boolean
C1511069 (UMLS CUI [1])
visual analog scale of COPD symptoms
Item
Achieves a composite VAS score of ≥120 (out of 400 maximum) on 4 or more days over the 7 days immediately prior to Visit 2.
boolean
C3536884 (UMLS CUI [1,1])
C1737716 (UMLS CUI [1,2])
ability of daily documentation
Item
Is able to complete a Daily Record Card.
boolean
C0920316 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
ability to show the correct inhaler technique
Item
Is able to demonstrate correct use of DISKUS/ACCUHALER.
boolean
C0419833 (UMLS CUI [1])
Item Group
EXCLUSION CRITERIA
C0680251 (UMLS CUI-1)
incomplete documentation of the daily record card
Item
Has less than 4 consecutive days with complete run-in DRC data within the 7 consecutive days prior to Visit 2.
boolean
C3845717 (UMLS CUI [1])
abnormal clinical haematology and chemistry or cortisol level
Item
Has (in the opinion of the investigator) a clinically significant abnormal clinical haematology and chemistry or cortisol value at Visit 1.
boolean
C1332129 (UMLS CUI [1])
C0428396 (UMLS CUI [2])
COPD exacerbation
Item
Has experienced a moderate or severe exacerbation of their COPD during the Run-In period.
boolean
C0740304 (UMLS CUI [1])
change in COPD medication or medication other than the permitted
Item
Subjects who have had a change to their COPD medication or taken non-permitted medications, other than "as required" use of VENTOLIN for the management of COPD exacerbations between Visits 1 and 2.
boolean
C0024117 (UMLS CUI [1,1])
C0580105 (UMLS CUI [1,2])
C1115771 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial